Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V7GC
|
||||
Former ID |
DIB008730
|
||||
Drug Name |
Rolafagrel
|
||||
Synonyms |
FCE-22178
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nephritis [ICD10:N00-N19, N25-N29] | Discontinued in Phase 2 | [1] | ||
Company |
Pharmacia & Upjohn AB
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H12N2O2
|
||||
Canonical SMILES |
C1(=Cc2cc(C(=O)O)ccc2CC1)n1cncc1
|
||||
CAS Number |
CAS 89781-55-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane-A synthase | Target Info | Inhibitor | [2] | |
BioCyc Pathway | C20 prostanoid biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
Platelet activation | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Prostaglandin Synthesis and Regulation | ||||
Arachidonic acid metabolism | |||||
Phase 1 - Functionalization of compounds | |||||
Eicosanoid Synthesis | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001438) | ||||
REF 2 | Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:707-10. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.